[Skip to Content]
[Skip to Content Landing]
Article
March 1972

Porphyria Cutanea TardaReport of a Case Treated With Phlebotomies and Supplemental Iron

Author Affiliations

Pittsburgh

From the Department of Dermatology, Western Pennsylvania Hospital, Pittsburgh.

Arch Dermatol. 1972;105(3):432-433. doi:10.1001/archderm.1972.01620060070016
Abstract

The presence of hyperferremia in many cases of porphyria cutanea tarda (PCT) has implied that iron may be directly related to abnormal porphyrin metabolism. Very suggestive evidence has been the deleterious effect of iron administered to patients predisposed to or treated for PCT. Conversely, a case is now reported of a patient in whom supplemental iron did not negate the salutary effect of phlebotomy therapy.

×